title: Dose-dense paclitaxel for advanced ovarian cancer.
authors.forename: Yue-Can
authors.initials: YC
authors.lastname: Zeng
authors.forename: Rong
authors.initials: R
authors.lastname: Wu
authors.forename: Zhao-Guo
authors.initials: ZG
authors.lastname: Xu
authors.forename: Feng
authors.initials: F
authors.lastname: Chi
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018394:CA-125 Antigen / Q000032:analysis; D016190:Carboplatin / Q000008:administration & dosage; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D017239:Paclitaxel / Q000008:administration & dosage*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D018394:CA-125 Antigen; D016190:Carboplatin; D017239:Paclitaxel